SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decrease in the sales to Rs. 2762.82 millions was observed for the quarter ended December 2023. The sales stood at Rs. 3024.05 millions during the similar quarter previous year.The Net Profit of the company registered a slight decline of -25.89% to Rs. 216.55  millions from Rs. 292.19 millions.The company reported a degrowth in operating Profit to 613.57 millions from 642.68 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 2762.82 3024.05 -8.64 8455.88 8614.75 -1.84 11519.57 9880.90 16.58
Other Income 71.14 83.58 -14.88 200.64 232.93 -13.86 332.82 424.97 -21.68
PBIDT 613.57 642.68 -4.53 1975.20 1890.42 4.48 2553.73 2362.02 8.12
Interest 210.54 223.83 -5.94 625.76 703.44 -11.04 921.66 955.45 -3.54
PBDT 403.03 418.85 -3.78 1349.44 1186.98 13.69 1365.59 1389.65 -1.73
Depreciation 135.56 154.25 -12.12 406.29 480.78 -15.49 573.62 1309.70 -56.20
PBT 267.47 264.60 1.08 943.15 706.20 33.55 791.97 79.95 890.58
TAX 50.92 -27.59 -284.56 255.16 -27.59 -1024.83 367.26 137.05 167.98
Deferred Tax 0.00 0.00 0.00 86.15 0.00 0.00 233.62 -109.17 -314.00
PAT 216.55 292.19 -25.89 687.99 733.79 -6.24 424.71 -57.10 -843.80
Equity 590.87 590.87 0.00 590.87 590.87 0.00 590.87 590.87 0.00
PBIDTM(%) 22.21 21.25 4.50 23.36 21.94 6.45 22.17 23.90 -7.26

Ind-Swift Lab. Share Price

132.00 -13.30 (-9.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×